Trial intelligence / Profile preview

Coronary heart disease angina treatment with Guanxin Shutong dripping pills vs capsules

CTR20131609Phase 2Completed

Sponsor
Buchang Pharmaceuticals
Start
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Guanxin Shutong Capsule in coronary arteriosclerosis, angina pectoris, sponsored by Buchang Pharmaceuticals. Started Feb 2014; status: completed.

02

Drugs

Guanxin Shutong Capsule
03

Conditions

coronary arteriosclerosisangina pectoris

Beyond the preview

Go deeper on CTR20131609.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20131609.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call